KRS 214.554: Breast Cancer Screening Program -- Data and analysis.

(1) There is established within the department a Breast Cancer Screening Program for

the purposes of:

(a) Reducing morbidity and mortality from breast cancer in women through early

detection and treatment; and

(b) Making breast cancer screening services of hig h quality and reasonable cost

available to women of all income levels throughout the Commonwealth and to

women whose economic circumstances or geographic location limits access to

breast cancer screening facilities.

(2) Services provided under the Breast C ancer Screening Program may be undertaken

by private contract for services or operated by the department and may include the

purchase, maintenance, and staffing of a truck, a van, or any other vehicle suitably

equipped to perform breast cancer screening. T he program may also provide

referral services for the benefit of women for whom further examination or

treatment is indicated by the breast cancer screening.

(3) The department may adopt a schedule of income -based fees to be charged for the

breast cancer s creening. The schedule shall be determined to make screening

available to the largest possible number of women throughout the Commonwealth.

The department shall, where practical, collect any available insurance proceeds or

other reimbursement payable on behalf of any recipient of a breast cancer screening

under KRS 214.552 to 214.556 and may adjust the schedule of fees to reflect

insurance contributions. All fees collected shall be credited to the fund.

(4) The department may accept any grant or award of fu nds from the federal

government or private sources for carrying out the provisions of KRS 214.552 to

214.556.

(5) The commissioner of the Department for Public Health shall provide data and

analysis upon request on the:

(a) Implementation and outcome from the Breast Cancer Screening Program

including, by geographic region, numbers of persons screened, numbers of

cancers detected, referrals for treatment, and reductions in breast cancer

morbidity and mortality;

(b) Development of quality assurance guidelines , including timetables, for breast

cancer screening under this section, and monitoring of the manner and effect

of implementation of those guidelines; and

(c) Funds appropriated, received, and spent for breast cancer control by fiscal

year.